Norwegian Occipital Ischemic Stroke Study

• Register: ClinicalTrials.gov
• Last refreshed on: 31 August 2015
• Main ID: NCT02307981
• Date of registration: 28/11/2014
• Prospective Registration: No
• Primary sponsor: Haukeland University Hospital
• Public title: Norwegian Occipital Ischemic Stroke Study NOR-OCCIP
• Scientific title: Management and Outcome of Visual Field Defects in Occipital Infarction (NOR-OCCIP)- A Multi-center Prospective Study
• Date of first enrolment: August 2013
• Target sample size: 75
• Recruitment status: Active, not recruiting
• URL: https://clinicaltrials.gov/show/NCT02307981
• Study type: Observational
• Study design: Observational Model: Case Control, Time Perspective: Prospective
• Phase: N/A

Countries of recruitment

Norway

Contacts

• Name: Kristin Modalsli Sand, MD
• Affiliation: Haukeland University Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Written consent obtained,

- age >18,

- acute occipital infarction on brain imaging and ability to cooperate for examination
with autoperimetry

Exclusion Criteria:

- Pathological processes that severely affect eyesight.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Visual Field Defect

Ischemic Stroke

Intervention(s)

Other: Training with vision teacher (visual rehabilitation)

Primary Outcome(s)

Visual Field defect [Time Frame: 6 months]

Secondary Outcome(s)

Quality of life and self reported Visual function [Time Frame: 6 months]

NIHSS [Time Frame: One week]

Change in Visual function [Time Frame: 6 months]

Secondary ID(s)

2012/2307

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Statped Vest

Helse Stavanger HF

St. Olavs Hospital

Stavanger Municipality